Corneal pharmacokinetics of topically applied azithromycin and clarithromycin

American Journal of Ophthalmology

Volumn 138, Issue 4, 2004, Pages 547-553

  Kuehne, Jonas J ^a   Yu, Anna Lisa T ^a   Holland, Gary N ^a   Ramaswamy, Anand ^a   Taban, Ryan ^a   Mondino, Bartly J ^a   Yu, Fei ^a   Rayner, Sylvia A ^a   Giese, Michael J ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORNEA; DOSE RESPONSE; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG SOLUTION; DRUG STABILITY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; EYE IRRITATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATED ORGAN; NONHUMAN; PRIORITY JOURNAL; RABBIT; SAMPLING; SUSPENSION; TIME;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLARITHROMYCIN; CORNEA; MODELS, ANIMAL; OPHTHALMIC SOLUTIONS; RABBITS; TISSUE DISTRIBUTION;

EID: 7044253253     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.04.071     Document Type: Article

References (21)

1. N.S. Chandra, M.F. Torres, K.L Winthrop Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis Am J Ophthalmol 132 2001 819 830
2. M.S. Chung, M.H. Goldstein, W.J. Driebe, B.H. Schwartz Mycobacterium chelonae keratitis after laser in situ keratomileusis successfully treated with medical therapy and flap removal Am J Ophthalmol 129 2000 382 384
3. J.G. Ford, A.J. Huang, S.C Pflugfelder Nontuberculous mycobacterial keratitis in South Florida Ophthalmology 105 1998 1652 1658
4. D. Freitas, L. Alvarenga, J Sampaio An outbreak of Mycobacterium chelonae infection after LASIK Ophthalmology 110 2003 276 285
5. S.F. Fulcher, R.C. Fader, R.H. Rosa Jr, G.P. Holmes Delayed-onset mycobacterial keratitis after LASIK Cornea 21 2002 546 554
6. H. Gelender, H.L. Carter, B Bowman Mycobacterium keratitis after laser in situ keratomileusis J Refract Surg 16 2000 191 195
7. C.L. Karp, S.S. Tuli, S.H Yoo Infectious keratitis after LASIK Ophthalmology 110 2003 503 510
8. G.A. Kouyoumdjian, S.L. Forstot, V.D. Durairaj, R.E. Damiano Infectious keratitis after laser refractive surgery Ophthalmology 108 2001 1266 1268
9. A. Solomon, C.L. Karp, D Miller Mycobacterium interface keratitis after laser in situ keratomileusis Ophthalmology 108 2001 2201 2208
10. M. Busin, D. Ponzin, R.C. Arffa Mycobacterium chelonae interface infection after endokeratoplasty Am J Ophthalmol 135 2003 393 395
11. R.H. Gross, G.N. Holland, S.J. Elias, R. Tuz Corneal pharmacokinetics of topical clarithromycin Invest Ophthalmol Vis Sci 36 1995 965 968
12. C.J. Helm, G.N. Holland, R Lin Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model Am J Ophthalmol 116 1993 700 707
13. J.H. Draize, G. Woodward, H.O. Calvery Methods for the study of irritation and toxicity of substances applied to the skin and mucous membranes J Pharmacol Exp Toxicol 82 1944 377 390
14. J.L. Davis, S.Y. Gardner, S.L Jones Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes J Vet Pharmacol Ther 25 2002 99 9104
15. T. Turcinov, S. Pepeljnjak Azithromycin potency determination: optimal conditions for microbiological diffusion method assay J Pharm Biomed Anal 17 1998 903 910
16. Lauderdale T, Chapin KC, Murray, PR. Reagents. In: Murray PR, Baron EJ, Pfaller MA, et al, editors. Manual of clinical microbiology, 7th ed. Washington, DC: ASM Press, 1999: 1669.
17. Steigbigel NH. Macrolides and clarithromycin. In: Mandell GL, Douglas RG, Bennett JE, Dolin R, editors, 5th ed. Philadelphia: Churchill Livingstone, 2000:371-374.
18. G.W. Amsden Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther 18 1996 56 72
19. Brown BA, Wallace RJ Jr, Onyi GO, et al. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180-184.
20. T. Tartaglione Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin Clin Ther 19 1997 626 638
21. B. Watt, A. Rayner, G. Harris Comparative activity of azithromycin against clinical isolates of mycobacteria J Antimicrob Chemother 38 1996 539 542